Orthopedics Manufacturers Won’t Cover the Cost of Defective Replacement Hips and Knees
The New York Times, in a groundbreaking expose today by Barry Meier, reveals that not only do the leading orthopedic companies not pay to cover defective hips and knees, but the expense falls onto Medicare, the patients, or the insurance industry. Moreover as Mr. Meier reports, the companies even profit from the failed devices when they sell the replacement hips and knees. Asked for comments by the Times, three out of six implant manufacturers did not bother to return reporters’ calls. Read the full story.